02/08/2007 - A statin-based drug candidate is being touted as a potential rival to Roche’s flu vaccine Tamiflu (oseltamivir phosphate) after its developers revealed yesterday that it showed “superiority” in the preclinic.The compound, called StatC is a new formulation of two already marketed drugs - any prescription statin, with another [undisclosed] molecule - which in combination “work to produce an antiviral effect that prevents influenza infection,” Canopus BioPharma said in a statement.
